Skip to main content
American Journal of Respiratory and Critical Care Medicine logoLink to American Journal of Respiratory and Critical Care Medicine
letter
. 2020 Oct 1;202(7):1062. doi: 10.1164/rccm.202005-1802LE

Reply to Ward et al.: Clonally Related Viable Nontuberculous Mycobacteria in Gastric Juice and Sputum in People with Cystic Fibrosis

PMCID: PMC7528803  PMID: 32521170

From the Authors:

We appreciate the congratulations offered by Ward and colleagues regarding our recent publication on the possible link between nontuberculous mycobacterial (NTM) pulmonary disease (PD) and gastroesophageal reflux disease (GERD) (1). As a basic-science laboratory dedicated to learning more about the biology, microbiology, and immunology of environmentally acquired NTM infections, the intersection of our work with gastroenterology is intriguing and timely. In the past, this group has certainly provided important data regarding the presence of Pseudomonas aeruginosa and Mycobacterium abscessus in gastric fluids and sputum of patients with cystic fibrosis (2, 3). Though both our groups commonly highlight a role for rapid-growing M. abscessus in the context of GERD, we believe that the slow-growing M. avium complex species will also emerge as an important group of NTM to investigate in future studies. Already, our colleagues have demonstrated the high prevalence of GERD in patients with M. avium complex PD (4, 5). We are in full concurrence with Ward and colleagues regarding the growing importance of the “aerodigestive” interaction for both the respiratory and gastrointestinal fields and believe this is a necessary and certainly opportune research area. We are delighted and thankful for our common interests and encourage other enthusiasts of NTM PD and cystic fibrosis to join us in studying the pathogenesis of NTM PD-GERD.

Supplementary Material

Supplements
Author disclosures

Footnotes

Originally Published in Press as DOI: 10.1164/rccm.202005-1802LE on June 10, 2020

Author disclosures are available with the text of this letter at www.atsjournals.org.

Contributor Information

Collaborators: on behalf of all the authors

References

  • 1.Dawrs SN, Kautz M, Chan ED, Honda JR.Mycobacterium abscessus and gastroesophageal reflux: an in vitro study [letter] Am J Respir Crit Care Med 2020202466–469. [DOI] [PubMed] [Google Scholar]
  • 2.Al-Momani H, Perry A, Stewart CJ, Jones R, Krishnan A, Robertson AG, et al. Microbiological profiles of sputum and gastric juice aspirates in cystic fibrosis patients. Sci Rep. 2016;6:26985. doi: 10.1038/srep26985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Al-Momani H, Perry A, Jones R, Bourke S, Doe S, Perry J, et al. Nontuberculous mycobacteria in gastrostomy fed patients with cystic fibrosis. Sci Rep. 2017;7:46546. doi: 10.1038/srep46546. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Koh WJ, Lee JH, Kwon YS, Lee KS, Suh GY, Chung MP, et al. Prevalence of gastroesophageal reflux disease in patients with nontuberculous mycobacterial lung disease. Chest. 2007;131:1825–1830. doi: 10.1378/chest.06-2280. [DOI] [PubMed] [Google Scholar]
  • 5.Thomson RM, Armstrong JG, Looke DF. Gastroesophageal reflux disease, acid suppression, and Mycobacterium avium complex pulmonary disease. Chest. 2007;131:1166–1172. doi: 10.1378/chest.06-1906. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplements
Author disclosures

Articles from American Journal of Respiratory and Critical Care Medicine are provided here courtesy of American Thoracic Society

RESOURCES